SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-140385
Filing Date
2020-05-12
Accepted
2020-05-12 16:02:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d925378d424b5.htm 424B5 287940
2 GRAPHIC g925378g27s60.jpg GRAPHIC 47585
3 GRAPHIC g925378g80u98.jpg GRAPHIC 18635
  Complete submission text file 0001193125-20-140385.txt   380387
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223585 | Film No.: 20869018
SIC: 2834 Pharmaceutical Preparations